Cost-effectiveness analysis of cinacalcet versus conventional care in the treatment of secondary hyperparathyroidism on chronic haemodialysis patients;Analisi costo-efficacia di cinacalcet più terapia standard versus terapia standard nel trattamento dei pazienti in dialisi con iperparatiroidismo secondario

PharmacoEconomics - Italian Research Articles

Volumn 10, Issue 1, 2008, Pages 13-22

  Ravasio, Roberto ^a   Giotta, N ^b   Marino, A ^b   Colombo, M ^b   Caligaris, F ^b   Cesano, G ^b   Grill, A ^b   Sassone, D ^b   Biamino, E ^b  

^a Adis International Ltd   (Italy)

^b Cardinal Massaja Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; CINACALCET; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; SEVELAMER;

ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; FEMALE; HEALTH CARE COST; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM;

EID: 40049088621     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03320637     Document Type: Article

References (22)